A multi-institutional team developed a chimeric antigen receptor (CAR ... KG2032 CAR T cells displayed strong anti-AML effects in a mouse model, and CAR natural killer cells showed similar ...

Biotechnology company Eutilex is developing a portfolio of immuno-oncology T cell, chimeric ... receptor CAR T program, for relapsed and refractory hematologic malignancy, targets human leukocyte ...